10x Genomics Inc - Ordinary Shares - Class A

10x Genomics Inc - Ordinary Shares - Class A

TXG

Market Cap$1.97B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
10x Genomics Inc - Ordinary Shares - Class A10x Genomics Inc - Ordinary Shares - Class A-10.8--25%3.30.1
$34.33

Target Price by Analysts

110.2% upside10x Genomics Target Price DetailsTarget Price
$42.06

Current Fair Value

157.5% upside

Undervalued by 157.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.97 Billion
Enterprise Value$1.67 Billion
Dividend Yield$0 (0%)
Earnings per Share$-2.18
Beta1.85
Outstanding Shares120,733,030

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-10.8
PEG17.55
Price to Sales3.27
Price to Book Ratio3.27
Enterprise Value to Revenue2.66
Enterprise Value to EBIT-8.85
Enterprise Value to Net Income-10
Total Debt to Enterprise0.06
Debt to Equity0.14

Revenue Sources

No data

Insider Trades

ESG Score

No data

About 10x Genomics Inc

CEO: Serge Saxonov